Publisher's Synopsis
Revises the second edition of 1984, integrating advances in the field of antiviral research advances driven by the devastating experience of AIDS as well as by new approaches in drug development. This edition, for example, witnesses the availability of new drugs such as azidothymidine against AIDS, ribavirin for respiratory syncytial infections, di